Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Regulatory News (LID)

  • There is currently no data for LID

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

12 Feb 2020 07:00

RNS Number : 6905C
LiDCO Group Plc
12 February 2020
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Lidco Group PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

NO

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 NO

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 NO

An event changing the breakdown of voting rights

NO

Other (please specify):

Periodic update

 NO

3. Full name of person(s) subject to thenotification obligation: iii

Ingalls & Snyder LLC ("I&S") and Ingalls & Snyder Value Partners LP ("ISVP").

4. Full name of shareholder(s) (if different from 3.):iv

I&S, on behalf of its clients, has dispositive authority over (i.e. the power and authorization to sell at I&S's discretion) 17,125,579 shares. In respect of 13,820,000 of such 17,125,579 shares ISVP (as beneficial owner) shares dispositive authority with I&S and has voting authority. So in respect of the 13,820,000 shares beneficially held by ISVP, I&S has and ISVP share dispositive authority and ISVP has voting authority.

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

6. Date on which issuer notified:

February 2, 2020

7. Threshold(s) that is/are crossed orreached: vi, vii

Interest in excess of 7% of issued share capital.

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary Shares of 0.5 pence ISIN GB0030546849

17,125,579

-

17,125,579

See note 4 above. I&S has dispositive authority over 17,125,579shares and ISVP has voting authority and shares dispositive authority in respect of 13,820,000 of such shares.

-

7.01% (Note: For these purposes we have assumed that dispositive authority is equivalent to voting rights).

-

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

N/A

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

N/A

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

17,125,579 (Note: For these purposes we have assumed that dispositive authority is equivalent to voting rights).

7.01% (Note: For these purposes we have assumed that dispositive authority is equivalent to voting rights).

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

N/A

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

14. Contact name:

Frank Stolba

15. Contact telephone number:

(001) (212) 269 - 7814

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLDBGDDSBBDGGB
Date   Source Headline
26th Jan 20064:38 pmPRNConvertible loan update
19th Jan 20067:00 amRNSProduct Development
19th Dec 20051:15 pmPRNResignation of a Director
8th Dec 20059:02 amPRNDirector Shareholding
18th Nov 20057:00 amRNSConversion of Loan
8th Nov 20057:01 amRNSPositive Study Data
3rd Nov 20057:00 amRNSUS Army Order
25th Oct 20057:01 amRNSClinical Advisory Board
18th Oct 20057:01 amRNSInterim Results
14th Oct 20051:39 pmPRNDirectorate Change
26th Sep 20059:11 amRNSNotice of Results
11th Aug 20057:02 amRNSUSD 2 Million Financing
14th Jul 20057:00 amRNSAdditional Listing
7th Jul 20057:01 amRNSNew Veterinary Application
23rd Jun 20054:00 pmRNSImpact of Review Paper
17th Jun 20057:00 amRNSBoard Appointment
16th Jun 20052:57 pmRNSAGM Statement
6th Jun 20052:38 pmPRNDirector Shareholding
1st Jun 20057:00 amRNSPositive Data
10th May 20052:20 pmPRNDirector Shareholding
9th May 20057:00 amRNSRegistration in Brazil
25th Apr 20057:00 amRNSAppointment of New Director
15th Apr 200511:46 amRNSDirector Shareholding
13th Apr 20057:00 amRNSDirector Share Options Award
7th Apr 20057:00 amRNSDirector Shareholding
30th Mar 20057:01 amRNSPreliminary Results
30th Mar 20057:01 amRNSProduct Approval in Denmark
24th Mar 20057:02 amRNSLaunch Of Software Upgrade
23rd Mar 200510:50 amPRNAdditional Listing
21st Mar 20057:02 amRNSSignificant Trial Results
15th Mar 20057:02 amRNSEuropean Approval
2nd Mar 20058:19 amRNSChange of Financial PR Agency
14th Feb 20057:00 amPRNMajor Clinical Trial
24th Jan 20053:25 pmPRNAdditional Listing
19th Jan 20054:16 pmPRNDirectorate Change
13th Jan 200511:28 amPRNAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.